Friday, May 1, 2026

Why Passionfruit is the New Superfruit You Need to Try

Amid the ongoing record heatwave, the subtropical fruit passion fruit harvest is in full swing in Namwon, Jeonbuk Autonomous Province.

The Silent Killer Awakens: North Korea’s “Hero” Submarine Ready for Nuclear Launch

North Korea's Hero Kim Kun Ok submarine may be ready for SLBM tests after maintenance, with significant activity observed at the base.

Screen Time Alert: Young Eyes Aging Faster Than Ever Before

Presbyopia affects younger individuals due to digital device use; cataracts are common in older adults. Regular eye exams are essential.

Tag: SK Biopharmaceuticals

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.